Cystic Fibrosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with cystic fibrosis (CF) of any age who are about to start a specific combination therapy called ETI (elexacaftor/tezacaftor/ivacaftor), as permitted under Italian medicines regulations
- People who are being cared for at one of the participating CF treatment centres in Italy
- People for whom informed consent has been obtained before joining the study
Who may not be able to join:
- People with cystic fibrosis who are not going to be starting ETI therapy
- People with cystic fibrosis who have already begun ETI therapy before the study enrolment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 055 566 2474
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference in DNA methylation level before and after the start of therapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.